Nomura Asset Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Nomura Asset Management’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-17,200	Closed	-$1.18M	–	993
2021 Q2	$1.18M	Hold	17,200	–	–	0.01%	830
2021 Q1	$1.33M	Buy	17,200 +8,800	+105%	+$811K	0.01%	794
2020 Q4	$831K	Hold	8,400	–	–	0.01%	836
2020 Q3	$1.19M	Buy	8,400 +1,600	+24%	+$267K	0.01%	751
2020 Q2	$1.34M	Buy	+6,800	New	+$1.41M	0.01%	699
2015 Q4	–	Sell	-10,000	Closed	-$407K	–	892
2015 Q3	$407K	Buy	+10,000	New	+$576K	0.01%	819

Other funds holding LKFT

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Nomura Asset Management's LKFT Position: Q3 2021 in Review

Nomura Asset Management sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2021, closing a stake of 17,200 shares — an estimated $1.18M sold.

Nomura Asset Management first reported a position in LKFT in Q3 2015 and held it in 6 quarters. The position peaked at $1.34M in Q2 2020. 81 funds tracked by Wall St. Rank hold LKFT as of Q3 2021.

Nomura Asset Management reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q3 2021 after selling out during the quarter.
Nomura Asset Management sold 17,200 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2021, an estimated $1.18M.
Nomura Asset Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2015 and held it in 6 quarters.
Nomura Asset Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $1.34M in Q2 2020.
81 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2021.

Based on Nomura Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.